A Study With SAGE-547 for Super-Refractory Status Epilepticus

Clinical trial NCT02477618 · COMPLETED

Trial details

NCT number: NCT02477618
Sponsor: Supernus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Super-Refractory Status Epilepticus

Start date: 2015-06-01
Primary completion: 2017-07-18
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.